两个新型和选择性释激活通道抗剂的分子作用机制
Xiangjin Kong1, Feifan Wang2, Yan Chen3
1The National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha 410081, China; Peptide and Small Molecule Drug R&D Platform, Furong Laboratory, Changsha 40081, China.
International journal of biological macromolecules
|September 18, 2023
概括
两种新型化合物C63368和C79413通过直接向Orai1.1,选择性地抑制释激活通道 (CRAC). 这些CRAC通道抑制剂在牛皮和结肠炎等自身免疫性疾病中显示出治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 由STIM1和Orai1形成的释激活 (CRAC) 通道是自身免疫性疾病治疗的关键标.
- 开发选择性CRAC通道抑制剂对于具有最小副作用的有效治疗至关重要.
研究的目的:
- 识别和描述CRAC通道的新型选择性抑制剂.
- 研究这些抑制剂对CRAC通道功能的作用机制.
- 在自身免疫疾病的临床前模型中评估这些化合物的治疗潜力.
主要方法:
- 高通量查以确定CRAC通道抑制剂.
- 生物物理测试以评估功效,选择性和作用机制 (例如,IC50的确定,目标外道选).
- 在体外对T淋巴细胞 (增殖,细胞因子产生) 的研究,以及使用牛皮和结肠炎小鼠模型的体内研究.
主要成果:
- 两种新的选择性CRAC通道抑制剂,C63368 (类) 和C79413 (含皮拉),被确定具有低微分子IC50s.
- 这些化合物直接抑制Orai1,而不会影响STIM1激活或依赖的非激活,显示出高选择性.
- 在体外,这些化合物抑制了T细胞的增殖和细胞因子的产生;在体内,它们改善了牛皮和结肠炎模型的症状,减少了血清细胞因子.
结论:
- C63368和C79413是针对Orai1.1的强效和选择性的CRAC通道抑制剂.
- 这些化合物在临床前的自身免疫性疾病模型中显示出显著的治疗疗效.
- 这些发现为开发新的CRAC道向药物提供了有价值的见解和模板分子.
相关概念视频
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
563
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
563
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
557
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
557
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
875
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
875
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.9K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.9K
01:17Antiepileptic Drugs: Calcium Channel Blockers
445
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
445